Monitor for receipt of the final regulatory approval, which is the sole remaining condition to close the transaction. The delay is procedural and not a deal-breaker, but any further extension or denial would be material.
Price Chart
Executive Summary
Vivani Medical disclosed that the closing of its previously announced merger, under which its subsidiary Cortigent will merge into ClearOne, is delayed beyond October 2026 because final regulatory approval has not yet been received. The parties expect the closing to occur shortly after receipt of such approval.
Key Facts
- The merger transaction involves Vivani's wholly owned subsidiary Cortigent merging with ClearOne's Merger Sub to become a wholly owned subsidiary of ClearOne.
- Vivani had anticipated the transaction would close in October 2026.
- Closing remains subject to receiving final regulatory approval.
- The parties expect closing to occur shortly after receipt of such approval.
Financial Impact
No financial figures disclosed; the filing provides a timeline update only.
Risk Factors
- Regulatory approval may be delayed further or denied, which would prevent the transaction from closing.
- The filing contains no new financial data or guidance; the market impact is limited to the timing uncertainty.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001753926-26-002036 |
| Document: 0001753926-26-002036-index-headers.html | 0001753926-26-002036 |
| Document: 0001753926-26-002036-index.html | 0001753926-26-002036 |
| Document: 0001753926-26-002036.txt | 0001753926-26-002036 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 30, 2026 2d ago | 8-K | $1.12 | awaiting T+20 | awaiting T+20 | $1.09 (−2.68%) |
Oct 29, 2026 3d ago | 8-K | $1.14 | awaiting T+20 | awaiting T+20 | $1.09 (−4.39%) |
Sep 25, 2026 5w ago | 424B5 | $1.25 $1.13 | ▲ +9.60% | ▲ +9.57% | $1.09 (+12.80%) |
Aug 17, 2026 10w ago | 8-K | $1.35 $1.23 | ▼ −8.89% | ▼ −6.91% | $1.09 (−19.26%) |
Jul 16, 2026 15w ago | 8-K | $1.35 $1.34 | ▼ −0.74% | ▼ −4.36% | $1.09 (−19.26%) |
Jul 7, 2026 16w ago | 8-K | $1.35 $1.33 | ▼ −1.48% | ▼ −2.81% | $1.09 (−19.26%) |
Jul 2, 2026 17w ago | Press Release | $1.26 $1.30 | ▲ +3.17% | ▲ +3.59% | $1.09 (−13.49%) |
Jun 30, 2026 17w ago | 8-K | $1.24 $1.30 | ▲ +4.84% | ▲ +5.87% | $1.09 (−12.10%) |
Jun 4, 2026 21w ago | 8-K | $1.28 $1.26 | ▼ −1.56% | ▼ −0.19% | $1.09 (−14.84%) |
Mar 26, 2026 31w ago | Press Release | $1.02 $1.39 | ▲ +36.27% | ▲ +23.53% | $1.09 (+6.86%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers